MariMed Inc. (MRMD.CN)
CAD 0.15
(-11.76%)
CAD 0.15
(-11.76%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 65.48 Million USD | 150.65% |
| 2022 | 26.12 Million USD | 591.38% |
| 2021 | -5.31 Million USD | -113.42% |
| 2020 | 39.61 Million USD | -5.62% |
| 2019 | 41.97 Million USD | 286.25% |
| 2018 | 10.86 Million USD | -27.68% |
| 2017 | 15.02 Million USD | 160.39% |
| 2016 | 5.77 Million USD | 86.81% |
| 2015 | 3.08 Million USD | 190.95% |
| 2014 | 1.06 Million USD | 12535.37% |
| 2013 | -8538.00 USD | 0.55% |
| 2012 | -8585.00 USD | 92.77% |
| 2011 | -118.8 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 67.03 Million USD | 2.38% |
| 2024 Q2 | 77.35 Million USD | 15.38% |
| 2023 Q4 | 65.48 Million USD | 29.05% |
| 2023 FY | 65.48 Million USD | 150.65% |
| 2023 Q1 | 43.38 Million USD | 66.08% |
| 2023 Q2 | 50.83 Million USD | 17.16% |
| 2023 Q3 | 50.74 Million USD | -0.18% |
| 2022 FY | 26.12 Million USD | 591.38% |
| 2022 Q1 | -9.35 Million USD | -75.87% |
| 2022 Q2 | 21.59 Million USD | 330.92% |
| 2022 Q4 | 26.12 Million USD | 24.51% |
| 2022 Q3 | 20.98 Million USD | -2.82% |
| 2021 Q2 | 6.55 Million USD | -50.15% |
| 2021 FY | -5.31 Million USD | -113.42% |
| 2021 Q1 | 13.13 Million USD | -66.84% |
| 2021 Q3 | -384.55 Thousand USD | -105.87% |
| 2021 Q4 | -5.31 Million USD | -1282.51% |
| 2020 FY | 39.61 Million USD | -5.62% |
| 2020 Q4 | 39.61 Million USD | -8.16% |
| 2020 Q2 | 44.86 Million USD | 0.15% |
| 2020 Q3 | 43.13 Million USD | -3.84% |
| 2020 Q1 | 44.79 Million USD | 6.72% |
| 2019 Q4 | 41.97 Million USD | 3.21% |
| 2019 Q2 | 37.89 Million USD | 59.34% |
| 2019 Q1 | 23.78 Million USD | 118.82% |
| 2019 Q3 | 40.66 Million USD | 7.33% |
| 2019 FY | 41.97 Million USD | 286.25% |
| 2018 Q4 | 10.86 Million USD | 76.62% |
| 2018 FY | 10.86 Million USD | -27.68% |
| 2018 Q2 | 11.25 Million USD | -24.72% |
| 2018 Q1 | 14.95 Million USD | -0.5% |
| 2018 Q3 | 6.15 Million USD | -45.33% |
| 2017 FY | 15.02 Million USD | 160.39% |
| 2017 Q1 | 6.07 Million USD | 5.21% |
| 2017 Q2 | 3.86 Million USD | -36.31% |
| 2017 Q3 | 7.2 Million USD | 86.36% |
| 2017 Q4 | 15.02 Million USD | 108.52% |
| 2016 Q1 | 3.87 Million USD | 25.37% |
| 2016 Q3 | 6.24 Million USD | 48.63% |
| 2016 Q4 | 5.77 Million USD | -7.55% |
| 2016 FY | 5.77 Million USD | 86.81% |
| 2016 Q2 | 4.19 Million USD | 8.45% |
| 2015 Q3 | 3.13 Million USD | -11.2% |
| 2015 Q1 | 1.94 Million USD | 83.19% |
| 2015 Q4 | 3.08 Million USD | -1.54% |
| 2015 Q2 | 3.53 Million USD | 81.66% |
| 2015 FY | 3.08 Million USD | 190.95% |
| 2014 Q2 | 91.84 Thousand USD | 1349.62% |
| 2014 Q4 | 1.06 Million USD | 151.48% |
| 2014 FY | 1.06 Million USD | 12535.37% |
| 2014 Q3 | 422.19 Thousand USD | 359.67% |
| 2014 Q1 | -7350.00 USD | 13.91% |
| 2013 Q2 | -2732.00 USD | 86.82% |
| 2013 Q4 | -8538.00 USD | -5.75% |
| 2013 Q1 | -20.73 Thousand USD | -141.49% |
| 2013 Q3 | -8074.00 USD | -195.53% |
| 2013 FY | -8538.00 USD | 0.55% |
| 2012 Q4 | -8585.00 USD | -276.37% |
| 2012 Q2 | -41.55 Thousand USD | 65.11% |
| 2012 Q1 | -119.1 Thousand USD | 0.0% |
| 2012 FY | -8585.00 USD | 92.77% |
| 2012 Q3 | -2281.00 USD | 94.51% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | -118.8 Thousand USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | -7826.075% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | -93470.928% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 8230.586% |
| The BC Bud Corporation | 225.15 Thousand CAD | -28982.446% |
| BioNxt Solutions Inc. | 4.53 Million CAD | -1345.315% |
| CordovaCann Corp. | 6.13 Million CAD | -968.016% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | -1314.833% |
| Captor Capital Corp. | -5.41 Million CAD | 1310.226% |
| City View Green Holdings Inc. | 1.49 Million CAD | -4270.502% |
| 1CM Inc. | 3.31 Million CAD | -1875.249% |
| Global Hemp Group Inc. | 3.55 Million CAD | -1743.405% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | -351.913% |
| IM Cannabis Corp. | 11.96 Million CAD | -447.08% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | -33942.111% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | -2546.852% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 1207.016% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 14678.551% |
| Ovation Science Inc. | 143.76 Thousand CAD | -45446.235% |
| Pharmadrug Inc. | 1.2 Million CAD | -5326.405% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -35055.159% |
| RAMM Pharma Corp. | -4.71 Million CAD | 1489.736% |
| RIV Capital Inc. | -101.38 Million CAD | 164.587% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 8307.056% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 74.804% |
| SLANG Worldwide Inc. | 20.83 Million CAD | -214.334% |
| 1933 Industries Inc. | 16.47 Million CAD | -297.367% |
| Red Light Holland Corp. | -13.56 Million CAD | 582.845% |
| Top Strike Resources Corp. | 13.24 Million CAD | -394.251% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 64034.074% |
| Adastra Holdings Ltd. | 2.2 Million CAD | -2870.529% |